We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Liquid Biopsies – Webinars and Online Events

Harnessing the Power of ddPCR to Advance Precision Oncology
Webinar

Harnessing the Power of ddPCR to Advance Precision Oncology

On-Demand
Liquid biopsies and the advent of blood-based diagnostics have emerged in recent years as promising alternatives and complements to tissue-based genomic and proteomic assays. Biodesix, a global leader in molecular diagnostics and assay design/development, leverages cutting-edge technology, including droplet digital PCR (ddPCR), to advance translational and clinical oncology research and to assist biopharma companies in delivering new, targeted, life-saving therapies to patients.

This presentation provides a comprehensive exploration of new blood-based diagnostics, including the development of a microsatellite instability (MSI) test on the ddPCR platform and the dynamic monitoring capabilities of ddPCR using circulating tumor DNA (ctDNA).
The Most Comprehensive Insights in Cancer Genomes: Translational Research content piece image
Webinar

The Most Comprehensive Insights in Cancer Genomes: Translational Research

On-Demand
This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.

From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.

The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.
Gain Insights Into Therapeutic Resistance With Single Cell RNA-Seq content piece image
Webinar

Gain Insights Into Therapeutic Resistance With Single Cell RNA-Seq

On-Demand
Watch this webinar to hear how researchers use scRNA-seq to develop a working model for combinational therapeutics to delay development of ITH and much more.
Advertisement